Review Article
Top Cited Papers
- 1 January 2004
- journal article
- review article
- Published by Taylor & Francis Ltd in Journal of Enzyme Inhibition and Medicinal Chemistry
- Vol. 19 (3), 199-229
- https://doi.org/10.1080/14756360410001689540
Abstract
Carbonic anhydrases (CAs, EC 4.2.1.1) are wide-spread enzymes, present in mammals in at least 14 different isoforms. Some of these isozymes are cytosolic (CA I, CA II, CA III, CA VII, CA XIII), others are membrane-bound (CA IV, CA IX, CA XII and CA XIV), CA V is mitochondrial and CA VI is secreted in the saliva and milk. Three cytosolic acatalytic forms are also known (CARP VIII, CARP X and CARP XI). The catalytically active isoforms, which play important physiological and patho-physiological functions, are strongly inhibited by aromatic and heterocyclic sulfonamides. The catalytic and inhibition mechanisms of these enzymes are understood in great detail, and this greatly helped the design of potent inhibitors, some of which possess important clinical applications. The use of such CA inhibitors (CAIs) as antiglaucoma drugs are discussed in detail, together with the recent developments that led to isozyme-specific and organ-selective inhibitors. A recent discovery is connected with the involvement of CAs and their sulfonamide inhibitors in cancer: many potent CAIs were shown to inhibit the growth of several tumor cell lines in vitro and in vivo, thus constituting interesting leads for developing novel antitumor therapies. Future prospects for drug design of inhibitors of these ubiquitous enzymes are dealt with. Although activation of CAs has been a controversial issue for some time, recent kinetic, spectroscopic and X-ray crystallographic experiments offered an explanation of this phenomenon, based on the catalytic mechanism. It has been demonstrated recently, that molecules that act as carbonic anhydrase activators (CAAs) bind at the entrance of the enzyme active site participating in facilitated proton transfer processes between the active site and the reaction medium. In addition to CA II-activator adducts, X-ray crystallographic studies have been also reported for ternary complexes of this isozyme with activators and anion (azide) inhibitors. Structure-activity correlations for diverse classes of activators is discussed for the isozymes for which the phenomenon has been studied, i.e, CA I, II, III and IV. The possible physiological relevance of CA activation/inhibition is also addressed, together with recent pharmacological/biomedical applications of such compounds in different fields of life sciences.Keywords
This publication has 103 references indexed in Scilit:
- Characterization of CA XIII, a Novel Member of the Carbonic Anhydrase Isozyme FamilyOnline Journal of Public Health Informatics, 2004
- Cyclodextrin Complexes of Sulfonamide Carbonic Anhydrase IOnhibitors As Long‐lasting Topically Acting Antiglaucoma AgentsJournal of Pharmaceutical Sciences, 2002
- The Extracellular Component of a Transport MetabolonOnline Journal of Public Health Informatics, 2002
- Carbonic anhydrases in plants and algaePlant, Cell & Environment, 2001
- Carbonic Anhydrase Inhibitors: Synthesis and Inhibition Against Isozymes I, II and IV of Topically Acting Antiglaucoma Sulfonamides Incorporatingcis-5-Norbornene-endo-3-Carboxy-2-Carboxamido MoietiesJournal of Enzyme Inhibition, 2001
- The Active Site Structure of Thalassiosira weissflogii Carbonic Anhydrase 1Biochemistry, 2000
- Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinomaEuropean Respiratory Journal, 1999
- Carbonic Anhydrase Activators. 3: Structure-Activity Correlations for a Series of Isozyme I1 ActivatorsJournal of Pharmaceutical Sciences, 1994
- Expression of carbonic anhydrase in neisseriae and other heterotrophic bacteriaJournal of Medical Microbiology, 1990
- Das Ferment Kohlensäureanhydrase im TierkörperThe Science of Nature, 1940